Header Logo

Connection

BIYKEM BOZKURT to Receptors, Glucagon

Back to Details
This is a "connection" page, showing publications BIYKEM BOZKURT has written about Receptors, Glucagon.
BIYKEM BOZKURT
Connection Strength
0.059
Receptors, Glucagon
  1. Baseline characteristics in the SYNCHRONIZE?-2 randomized phase 3 trial of survodutide, a glucagon receptor/GLP-1 receptor dual agonist, for obesity in people with type 2 diabetes. Diabetes Obes Metab. 2026 Feb; 28(2):1490-1498.
    View in: PubMed
    Score: 0.059
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.